INTRAPULMONARY LYMPHADENOPATHY

This adverse event was reported 20 times

These drugs are most commonly taken by patients reporting INTRAPULMONARY LYMPHADENOPATHY:

# Drug Count
0 CABOZANTINIB 5
1 ACETAMINOPHEN 4
2 NIVOLUMAB 4
3 VITAMIN E 4
4 ACETAMINOPHEN 500MG 3
5 ACETAMINOPHEN TABLET EXTENDED RELEASE 3
6 ALBUTEROL SULFATE 3
7 CLINDAMYCIN 3
8 DEXAMETHASONE 3
9 DEXAMETHASONE 1.5 MG 3
See all common drugs associated with INTRAPULMONARY LYMPHADENOPATHY

INTRAPULMONARY LYMPHADENOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERTUGLIFLOZIN 1 0.0009
1 PROCHLORPERAZINE EDISYLATE 1 0.0008
2 NIACIN 3 0.0003
3 SELENIUM 1 0.0002
4 DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 3 0.0002
5 ESOMEPRAZOLE MAGNESIUM DIHYDRATE 3 0.0002
6 EVEROLIMUS TABLETS 3 0.0002
7 VITAMIN E 4 0.0001
8 ACETYLCYSTEINE 1 0.0001
9 CABOZANTINIB 5 0.0001
See all drugs enriched for association with INTRAPULMONARY LYMPHADENOPATHY